OPCM
XRAY icon

Osborne Partners Capital Management’s Dentsply Sirona XRAY Stock Holding History

Osborne Partners Capital Management’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-290,048
Closed -$3.68M – 214
2025
Q3 		$3.68M Sell
290,048
-11,699
-4% -$170K 0.19% 109
2025
Q2 		$4.79M Buy
301,747
+2,732
+0.9% +$40.9K 0.25% 104
2025
Q1 		$4.47M Buy
299,015
+135
+0% +$2.39K 0.26% 105
2024
Q4 		$5.67M Sell
298,880
-33,543
-10% -$709K 0.33% 96
2024
Q3 		$9M Buy
332,423
+3,556
+1% +$90.8K 0.51% 72
2024
Q2 		$8.19M Buy
328,867
+16,764
+5% +$481K 0.49% 70
2024
Q1 		$10.4M Buy
312,103
+10,660
+4% +$364K 0.64% 61
2023
Q4 		$10.7M Sell
301,443
-411
-0.1% -$13K 0.7% 49
2023
Q3 		$10.3M Buy
301,854
+591
+0.2% +$22.5K 0.76% 48
2023
Q2 		$12.1M Buy
301,263
+1,211
+0.4% +$48.2K 0.87% 34
2023
Q1 		$11.8M Sell
300,052
-9,815
-3% -$360K 0.86% 33
2022
Q4 		$9.87M Sell
309,867
-45,607
-13% -$1.37M 0.77% 42
2022
Q3 		$10.1M Buy
355,474
+25,643
+8% +$876K 0.84% 36
2022
Q2 		$11.8M Sell
329,831
-1,795
-0.5% -$72.6K 0.9% 36
2022
Q1 		$16.3M Buy
331,626
+34,018
+11% +$1.8M 1.2% 23
2021
Q4 		$16.6M Buy
297,608
+101,834
+52% +$5.6M 1.21% 22
2021
Q3 		$11.4M Buy
195,774
+11,875
+6% +$732K 0.91% 35
2021
Q2 		$11.6M Buy
183,899
+14,871
+9% +$980K 0.96% 30
2021
Q1 		$10.8M Buy
169,028
+9,555
+6% +$554K 0.98% 30
2020
Q4 		$8.35M Buy
159,473
+1,522
+1% +$75.1K 1.02% 28
2020
Q3 		$6.91M Buy
157,951
+7,617
+5% +$337K 1.39% 22
2020
Q2 		$6.62M Buy
150,334
+6,205
+4% +$262K 1.42% 20
2020
Q1 		$5.6M Buy
144,129
+79,909
+124% +$4.07M 1.46% 20
2019
Q4 		$3.63M Sell
64,220
-2,215
-3% -$123K 0.74% 52
2019
Q3 		$3.54M Sell
66,435
-2,285
-3% -$123K 0.71% 54
2019
Q2 		$4.01M Buy
68,720
+205
+0.3% +$11K 0.77% 53
2019
Q1 		$3.4M Sell
68,515
-1,250
-2% -$55K 0.66% 58
2018
Q4 		$2.6M Buy
+69,765
New +$2.54M 0.39% 78

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Osborne Partners Capital Management's XRAY Position: Q4 2025 in Review

Osborne Partners Capital Management sold out of Dentsply Sirona (XRAY) in Q4 2025, closing a stake of 290,048 shares — an estimated $3.68M sold.

Osborne Partners Capital Management first reported a position in XRAY in Q4 2018 and held it in 28 quarters. The position peaked at $16.6M in Q4 2021. 362 funds tracked by Wall St. Rank hold XRAY as of Q4 2025.

  • Osborne Partners Capital Management reported no remaining Dentsply Sirona position as of Q4 2025 after selling out during the quarter.
  • Osborne Partners Capital Management sold 290,048 Dentsply Sirona shares in Q4 2025, an estimated $3.68M.
  • Osborne Partners Capital Management first reported a position in Dentsply Sirona in Q4 2018 and held it in 28 quarters.
  • Osborne Partners Capital Management's Dentsply Sirona position peaked at $16.6M in Q4 2021.
  • 362 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2025.

Based on Osborne Partners Capital Management's 13F filing for Q4 2025, filed 27 Jan 2026.